The adiponectin‐to‐leptin ratio (A/L ratio) has been appointed as a potential marker of adipose tissue dysfunction and metabolic disorders, with a higher A/L ratio suggesting a more favourable metabolic profile.3 This evidence concerns the gene ADIPOQ and metabolic disease.